Cold-EEZE Claims Chilled By Zicam Maker’s NAD Challenge
This article was originally published in The Tan Sheet
NAD says ProPhase should alter claims about how much Cold-EEZE reduces the duration of colds, in a decision on a case brought by competitor Matrixx Initiatives. The advertising watchdog group calls for tweaks to a number of ProPhase’s claims.
You may also be interested in...
Matrixx aims to make more consumers aware they can shorten the duration of a cold rather than treat the symptoms without affecting how long the cold lasts. New advertising introduces the “Cold Monster” to remind consumers to use Zicam products when they feel the first signs of a “monster of a cold.”
Dietary ingredients identified in recent FDA warning letters as linked to disease claims by marketers directing customers to scientific literature include omega-3 fatty acid, ginkgo biloba, glucosamine curcumin and vitamin D.
Approvals by FDA also include revised container and consumer information labeling for J&J's Men’s Rogaine to align with labeling for Women’s Rogaine; bonus-pack labeling for Bayer AG’s Aleve; and